{"record_key":"cellplex-biosciences-inc","identifier":"cellplex-biosciences-inc","external_key":"0BA4EC","title":"CellPlex Biosciences, Inc.","summary":null,"url":"https://inventions.pitt.edu/startups/cellplex-biosciences-inc","json_url":"https://inventions.pitt.edu/startups/cellplex-biosciences-inc.json","object_key":"startups","description":"CellPlex Biosciences is developing precision tools to help transplanted organs last longer. Its platform examines gene activity in transplant tissue to identify the biological pathways driving rejection, with the goal of helping clinicians select anti-rejection treatments suited to each patient. Machine learning supports efforts to focus testing on the most informative genes. [1]: https://www.innovation.pitt.edu/pitt-innovators-startup-leverages-machine-learning-to-extend-life-of-transplanted-organs/\nFounded by University of Pittsburgh transplant researcher Rakesh Sindhi, CellPlex builds on decades of research and tissue samples from UPMC's transplant program. By connecting molecular insights with treatment selection, the company aims to improve long-term organ protection and reduce the need for repeat transplantation. [2]: https://www.surgery.pitt.edu/news/dr-rakesh-sindhi-launches-venture-focused-extending-organ-lifespan","attributes":[{"key":"sector","label":"Sector","values":["Diagnostic"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Immunology"]},{"key":"founders","label":"Founders","values":["Rakesh Sindhi"]}],"related":[]}